Mednax receives consensus rating of “buy”: 5 things to know

Mednax shares have received a consensus recommendation of “buy” from the 12 ratings firms that are currently covering the firm, according to a Storm Investor report.

Advertisement

Here are five things to know:

1. The average one-year price objective for the stock is $83.40.

2. Mednax has a market cap of $6.78 billion.

3. The firm has a one-year low of $64.12 and a one-year high of $86.09.

4. The company’s 50-day moving average is $72.11 and its 200-day moving average is $76.93.

5. Mednax provides anesthesia care at more than 90 hospitals and over 100 ambulatory surgery centers and office-based practices.

More articles on anesthesia:
National Health Council names ASA CEO Paul Pomerantz treasurer: 3 points
Weill Cornell Medical College names Dr. Sheida Tabaie the anesthesia department’s Global Health Fellow: 4 points
A kidney donor death highlights the dangers of anesthesia — 4 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.